$GBTG
Global Business Travel Group, Inc.

2021 Form 10-K Financial Statement

#000110465922028779 Filed on March 01, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $477.0M $529.0M
YoY Change -9.83% -39.89%
Gross Profit $286.0M $264.0M
YoY Change 8.33% -78.69%
Gross Profit Margin
Selling, General & Admin $12.86M $583.3K
YoY Change 2105.53% -99.93%
% of Gross Profit 4.5% 0.22%
Research & Development $264.0M $277.0M
YoY Change -4.69%
% of Gross Profit 92.31% 104.92%
Depreciation & Amortization $154.0M $148.0M
YoY Change 4.05% 4.96%
% of Gross Profit 53.85% 56.06%
Operating Expenses $12.86M $583.3K
YoY Change 2105.52% 31377.77%
Operating Profit $273.1M $263.4M
YoY Change 3.69% -78.74%
Interest Expense $5.465K $414.00
YoY Change 1220.05% -100.0%
% of Operating Profit 0.0% 0.0%
Other Income/Expense, Net $19.06M -$19.06M
YoY Change -200.03% 535.28%
Pretax Income $6.200M -$19.64M
YoY Change -131.56% 1061616.76%
Income Tax -$186.0M -$145.0M
% Of Pretax Income -3000.05%
Net Earnings $6.200M -$19.64M
YoY Change -131.56% 1059897.84%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $60.72K -$200.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.3K $257.9K
YoY Change -37.46%
Cash & Equivalents $516.0M $257.9K $584.0M
Short-Term Investments
Other Short-Term Assets $495.9K $1.125M
YoY Change -55.93% 60724.86%
Inventory
Prepaid Expenses $1.125M
Receivables $381.0M $144.0M
Other Receivables $61.00M $86.00M
Total Short-Term Assets $657.2K $1.383M $1.383M
YoY Change -52.49% 74663.78%
LONG-TERM ASSETS
Property, Plant & Equipment $275.0M $411.0M
YoY Change -33.09%
Goodwill $1.028B
YoY Change
Intangibles
YoY Change
Long-Term Investments $817.4M $817.0M
YoY Change 0.05%
Other Assets $323.0M $79.00M
YoY Change 308.86%
Total Long-Term Assets $817.4M $817.0M $817.0M
YoY Change 0.05%
TOTAL ASSETS
Total Short-Term Assets $657.2K $1.383M $1.383M
Total Long-Term Assets $817.4M $817.0M $817.0M
Total Assets $818.0M $818.4M $818.4M
YoY Change -0.04% 44236043.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.560M $383.2K
YoY Change 1612.19%
Accrued Expenses $435.0M $363.0M
YoY Change 19.83%
Deferred Revenue
YoY Change
Short-Term Debt $5.800M $1.500M
YoY Change 286.67%
Long-Term Debt Due $3.000M $7.000M
YoY Change -57.14%
Total Short-Term Liabilities $14.40M $2.257M $2.257M
YoY Change 538.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $84.53M $103.2M
YoY Change -18.11%
Total Long-Term Liabilities $84.53M $103.2M
YoY Change -18.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.40M $2.257M $2.257M
Total Long-Term Liabilities $84.53M $103.2M
Total Liabilities $98.93M $105.5M $105.5M
YoY Change -6.21%
SHAREHOLDERS EQUITY
Retained Earnings -$103.9M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $719.1M -$103.9M $712.9M
YoY Change
Total Liabilities & Shareholders Equity $818.0M $818.4M $818.4M
YoY Change -0.04% 44236043.78%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $6.200M -$19.64M
YoY Change -131.56% 1059897.84%
Depreciation, Depletion And Amortization $154.0M $148.0M
YoY Change 4.05% 4.96%
Cash From Operating Activities -$4.025M -$2.441M
YoY Change 64.87%
INVESTING ACTIVITIES
Capital Expenditures -$44.00M -$47.00M
YoY Change -6.38% -24.19%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$816.8M
YoY Change -100.0% 3167.24%
Cash From Investing Activities $0.00 -$816.8M
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $551.0M $4.000M
YoY Change 13675.0%
Cash From Financing Activities 3.928M 819.5M
YoY Change -99.52%
NET CHANGE
Cash From Operating Activities -4.025M -2.441M
Cash From Investing Activities 0.000 -816.8M
Cash From Financing Activities 3.928M 819.5M
Net Change In Cash -96.60K 257.9K
YoY Change -137.46%
FREE CASH FLOW
Cash From Operating Activities -$4.025M -$2.441M
Capital Expenditures -$44.00M -$47.00M
Free Cash Flow $39.98M $44.56M
YoY Change -10.29% -28.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Assets Current
AssetsCurrent
657192
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1383127
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001820872
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2021 dei City Area Code
CityAreaCode
212
CY2021 dei Local Phone Number
LocalPhoneNumber
515-3200
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39576
CY2021 dei Entity Registrant Name
EntityRegistrantName
Apollo Strategic Growth Capital
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0598290
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
9 West 57th Street
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
43rd Floor
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q2 dei Entity Public Float
EntityPublicFloat
798840180
CY2021 dei Auditor Firm
AuditorFirmId
100
CY2021 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2021 dei Auditor Location
AuditorLocation
New York, New York
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161277
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257872
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
495915
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1125255
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
817356537
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
816985533
CY2021Q4 us-gaap Assets
Assets
818013729
CY2020Q4 us-gaap Assets
Assets
818368660
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6560426
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
383164
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2040211
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
373517
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5800000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00005
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1500000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14400637
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2256681
CY2021Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
55943533
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
74642310
CY2021Q4 apsg Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
28588350
CY2020Q4 apsg Deferred Underwriting Compensation Noncurrent
DeferredUnderwritingCompensationNoncurrent
28588350
CY2021Q4 us-gaap Liabilities
Liabilities
98932520
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1854
CY2020Q4 us-gaap Liabilities
Liabilities
105487341
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
816810000
CY2021 us-gaap Interest Expense
InterestExpense
5465
CY2020 us-gaap Interest Expense
InterestExpense
414
CY2021 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
CY2020 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2344508
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
816810000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00005
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97729812
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-103929702
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-97728791
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-103928681
CY2019 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18698777
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6179734
CY2020 apsg Formation And Operating Costs Paid By Related Parties
FormationAndOperatingCostsPaidByRelatedParties
27607
CY2019 apsg Formation And Operating Costs Paid By Related Parties
FormationAndOperatingCostsPaidByRelatedParties
3707
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
371004
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
175533
CY2020 apsg Costs Associated With Warrant Liabilities
CostsAssociatedWithWarrantLiabilities
2344508
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18698777
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
16889088
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-629340
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1123401
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818013729
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818368660
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
200650
CY2020 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
46669
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12663776
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
536614
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1853
CY2021 us-gaap Operating Expenses
OperatingExpenses
12864426
CY2020 us-gaap Operating Expenses
OperatingExpenses
583283
CY2019 us-gaap Operating Expenses
OperatingExpenses
1853
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
371004
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
175533
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
16889088
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
19064316
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19058477
CY2021 us-gaap Net Income Loss
NetIncomeLoss
6199890
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19641760
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1853
CY2019 apsg Adjustments To Additional Paid In Capital Capital Contribution
AdjustmentsToAdditionalPaidInCapitalCapitalContribution
3707
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-1853
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1854
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
328959
CY2020 apsg Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
84617734
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-19641760
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-103928681
CY2021 us-gaap Net Income Loss
NetIncomeLoss
6199890
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-97728791
CY2021 us-gaap Profit Loss
ProfitLoss
6199890
CY2020 us-gaap Profit Loss
ProfitLoss
-19641760
CY2019 us-gaap Profit Loss
ProfitLoss
-1853
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
257872
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257872
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-761757
CY2021 apsg Increase Decrease In Advances From Related Parties
IncreaseDecreaseInAdvancesFromRelatedParties
2035989
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4024828
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2441248
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
816810000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-816810000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
816810000
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
18336200
CY2020 apsg Payment Of Underwriter Commission
PaymentOfUnderwriterCommission
-16336200
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
800880
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4300000
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1500000
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
371767
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3928233
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
819509120
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-96595
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161277
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257872
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020 apsg Deferred Underwriters Commissions Charged To Temporary Equity
DeferredUnderwritersCommissionsChargedToTemporaryEquity
28588350
CY2020 apsg Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
345910
CY2019 apsg Deferred Offering Costs Paid By Related Party
DeferredOfferingCostsPaidByRelatedParty
3707
CY2020 apsg Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
1144924
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
750000000
CY2020Q4 apsg Transaction Costs
TransactionCosts
41389428
CY2020Q4 apsg Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
15000000
CY2020Q4 apsg Deferred Underwriting Commissions
DeferredUnderwritingCommissions
26250000
CY2020Q4 apsg Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
26250000
CY2020Q4 apsg Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
2344508
CY2021 apsg Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
P180D
CY2020Q4 apsg Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
100000
CY2021 apsg Condition For Future Business Combination Use Of Proceeds Percentage
ConditionForFutureBusinessCombinationUseOfProceedsPercentage
100
CY2020 apsg Condition For Future Business Combination Threshold Percentage Ownership
ConditionForFutureBusinessCombinationThresholdPercentageOwnership
100
CY2021 apsg Percentage Of Aggregate Fair Market Value Of Asset
PercentageOfAggregateFairMarketValueOfAsset
0.80
CY2021 apsg Threshold Number Of Days To Sell Their Public Shares By Means Of Tender Offer
ThresholdNumberOfDaysToSellTheirPublicSharesByMeansOfTenderOffer
2
CY2021Q4 apsg Condition For Future Business Combination Threshold Net Tangible Assets
ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
5000001
CY2021 apsg Threshold Number Of Days To Sell Their Public Shares By Means Of Tender Offer
ThresholdNumberOfDaysToSellTheirPublicSharesByMeansOfTenderOffer
2
CY2021 apsg Threshold Business Days For Redemption Of Public Shares
ThresholdBusinessDaysForRedemptionOfPublicShares
10
CY2020 apsg Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
100000
CY2021Q4 apsg Sale Of Public Offering Costs
SaleOfPublicOfferingCosts
800877
CY2021 apsg Payments For Investment Of Cash In Trust Account
PaymentsForInvestmentOfCashInTrustAccount
817356537
CY2021 apsg Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
100000
CY2021Q4 apsg Working Capital Deficit
WorkingCapitalDeficit
13700000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14400000
CY2021Q4 us-gaap Cash
Cash
161000
CY2020Q4 apsg Maximum Allowed Dissolution Expenses
MaximumAllowedDissolutionExpenses
100000
CY2021Q4 apsg Earnout Shares
EarnoutShares
15000000
CY2021 apsg Term For Submitting Or Filing Shelf Covering Issuance And Resale Of All Registrable Securities On Delayed Or Continuous Basis
TermForSubmittingOrFilingShelfCoveringIssuanceAndResaleOfAllRegistrableSecuritiesOnDelayedOrContinuousBasis
P30D
CY2021 apsg Term For Declaring Shelf Effective After Filing
TermForDeclaringShelfEffectiveAfterFiling
P60D
CY2021 apsg Term For Declaring Shelf Effective After Filing If Sec Notifies That It Will Review Shelf
TermForDeclaringShelfEffectiveAfterFilingIfSecNotifiesThatItWillReviewShelf
P90D
CY2021 apsg Term For Declaring Shelf Effective After Date When Entity Is Notified Orally Or In Writing Whichever Is Earlier By Sec That Shelf Will Not Be Reviewed Or Will Notbesubjecttofurther Review
TermForDeclaringShelfEffectiveAfterDateWhenEntityIsNotifiedOrallyOrInWritingWhicheverIsEarlierBySecThatShelfWillNotBeReviewedOrWillNotbesubjecttofurtherReview
P10D
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;text-decoration-line:underline;text-decoration-style:solid;">Concentration of Credit Risk</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021 apsg Adjustments To Additional Paid In Capital Stock Issued Underwriter Discounts
AdjustmentsToAdditionalPaidInCapitalStockIssuedUnderwriterDiscounts
44924550
CY2020Q4 apsg Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
2344508
CY2021 apsg Placement Fee Percentage
PlacementFeePercentage
0.035
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2021 us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><i style="font-weight:normal;text-decoration-line:underline;text-decoration-style:solid;">Derivative Financial Instruments</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC 815, “<i style="font-style:italic;">Derivatives and Hedging</i>.” The Company’s derivative instruments are recorded at fair value as of the Public Offering (October 6, 2020) and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The Company has determined the Warrants are a derivative instrument. As the Warrants meet the definition of a derivative the Warrants are measured at fair value at issuance and at each reporting date in accordance with ASC 820, “<i style="font-style:italic;">Fair Value Measurement</i>,” with changes in fair value recognized in the statement of operations in the period of change.</p>
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2040211
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
373517
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2020Q4 apsg Underwriting Cash Discount Per Unit
UnderwritingCashDiscountPerUnit
0.20
CY2020Q4 apsg Deferred Fee Per Unit
DeferredFeePerUnit
0.35
CY2020Q4 apsg Aggregate Deferred Underwriting Fee Payable
AggregateDeferredUnderwritingFeePayable
28588350
CY2021 apsg Contingent Fees With Service Provider
ContingentFeesWithServiceProvider
7000000.0
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
39451134
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
39451134
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021 apsg Units Issued During Period Shares New Issues
UnitsIssuedDuringPeriodSharesNewIssues
39451134
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
57753222
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00005
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 apsg Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2021 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2021 apsg Initial Business Combination Shares Issuable As Percent Of Outstanding Shares
InitialBusinessCombinationSharesIssuableAsPercentOfOutstandingShares
0.20
CY2021 apsg Schedule Of Fair Value Of Derivative Feature Of Warrants
ScheduleOfFairValueOfDerivativeFeatureOfWarrants
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:66.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:66.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:66.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:66.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Risk-free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1.31</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected life of grants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> years</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 5.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">years</p></td></tr><tr><td style="vertical-align:bottom;width:66.26%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Expected volatility of underlying shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 18.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">10.0 - 30.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:66.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt;">Dividends</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.98%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table>
CY2021Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
55943533
CY2020Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
74642310
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18698777
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
16889088

Files In Submission

Name View Source Status
0001104659-22-028779-index-headers.html Edgar Link pending
0001104659-22-028779-index.html Edgar Link pending
0001104659-22-028779.txt Edgar Link pending
0001104659-22-028779-xbrl.zip Edgar Link pending
apsg-20211231.xsd Edgar Link pending
apsg-20211231x10k.htm Edgar Link pending
apsg-20211231x10k_htm.xml Edgar Link completed
apsg-20211231xex31d1.htm Edgar Link pending
apsg-20211231xex31d2.htm Edgar Link pending
apsg-20211231xex32d1.htm Edgar Link pending
apsg-20211231xex32d2.htm Edgar Link pending
apsg-20211231_cal.xml Edgar Link unprocessable
apsg-20211231_def.xml Edgar Link unprocessable
apsg-20211231_lab.xml Edgar Link unprocessable
apsg-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending